SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,000 | -93.7% | 50,200 | -86.2% | 0.00% | -100.0% |
| Q2 2023 | $474,000 | +3.7% | 364,869 | +40.7% | 0.00% | 0.0% |
| Q1 2023 | $457,000 | -42.1% | 259,399 | +3.3% | 0.00% | -33.3% |
| Q4 2022 | $789,000 | -43.5% | 251,174 | -11.9% | 0.00% | -50.0% |
| Q3 2022 | $1,397,000 | +18.3% | 285,163 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $1,181,000 | +14.7% | 285,163 | +60.9% | 0.01% | +25.0% |
| Q1 2022 | $1,030,000 | -22.5% | 177,200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,329,000 | -16.8% | 177,200 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,597,000 | -24.7% | 177,200 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $2,121,000 | -4.5% | 177,200 | 0.0% | 0.01% | -22.2% |
| Q1 2021 | $2,220,000 | -19.7% | 177,200 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $2,765,000 | +148.4% | 177,200 | +50.4% | 0.01% | +100.0% |
| Q3 2020 | $1,113,000 | +5.4% | 117,810 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,056,000 | +40.8% | 117,810 | 0.0% | 0.01% | +20.0% |
| Q1 2020 | $750,000 | -26.4% | 117,810 | -3.2% | 0.01% | 0.0% |
| Q4 2019 | $1,019,000 | -7.5% | 121,713 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $1,102,000 | -15.9% | 121,713 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $1,311,000 | +14.7% | 121,713 | +1.6% | 0.01% | +16.7% |
| Q1 2019 | $1,143,000 | -2.6% | 119,825 | +17.2% | 0.01% | -14.3% |
| Q4 2018 | $1,173,000 | -32.3% | 102,200 | 0.0% | 0.01% | -22.2% |
| Q3 2018 | $1,732,000 | +0.8% | 102,200 | -15.5% | 0.01% | 0.0% |
| Q2 2018 | $1,718,000 | -25.2% | 120,970 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $2,298,000 | +15.4% | 120,970 | -0.3% | 0.01% | +20.0% |
| Q4 2017 | $1,991,000 | +9.3% | 121,388 | 0.0% | 0.01% | +11.1% |
| Q3 2017 | $1,821,000 | -14.7% | 121,388 | -50.0% | 0.01% | +50.0% |
| Q2 2017 | $2,136,000 | +205.1% | 242,776 | +80.3% | 0.01% | +50.0% |
| Q1 2017 | $700,000 | +40.6% | 134,622 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $498,000 | -20.1% | 134,622 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $623,000 | -20.0% | 134,622 | 0.0% | 0.00% | -20.0% |
| Q2 2016 | $779,000 | -4.3% | 134,622 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $814,000 | -38.4% | 134,622 | -7.0% | 0.01% | -37.5% |
| Q4 2015 | $1,321,000 | +64.7% | 144,736 | +1.8% | 0.01% | +60.0% |
| Q3 2015 | $802,000 | -26.4% | 142,161 | +44.8% | 0.01% | -16.7% |
| Q2 2015 | $1,089,000 | -29.2% | 98,153 | 0.0% | 0.01% | -33.3% |
| Q1 2015 | $1,539,000 | +9.6% | 98,153 | +6.3% | 0.01% | +12.5% |
| Q4 2014 | $1,404,000 | +41.0% | 92,314 | 0.0% | 0.01% | +33.3% |
| Q3 2014 | $996,000 | -29.4% | 92,314 | 0.0% | 0.01% | -25.0% |
| Q2 2014 | $1,410,000 | -15.5% | 92,314 | 0.0% | 0.01% | -20.0% |
| Q1 2014 | $1,669,000 | +15.7% | 92,314 | -11.1% | 0.01% | +25.0% |
| Q4 2013 | $1,442,000 | +39.1% | 103,844 | +5.0% | 0.01% | +33.3% |
| Q3 2013 | $1,037,000 | -3.1% | 98,936 | -27.8% | 0.01% | 0.0% |
| Q2 2013 | $1,070,000 | – | 137,015 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |